Dr. Linda Rhodes V.M.D., Ph.D. is Chief Executive Officer of Aratana

Kansas City Business Journal | Aratana Therapeutics Inc. has bought the licenses

1 day ago . Venture investors have fed animal-health company Aratana Therapeutics Inc.

Aratana Therapeutics licenses and develops proprietary, patent-protected

2 days ago . Aratana Therapeutics Completes $15 Million Series B Financing . 7, 2011 -- /

1 day ago . BV 5 Portfolio Company Aratana Therapeutics Completes $15 Million Series B

ARATANA THERAPEUTICS. Regulation D Filing Loading.. (source: SEC.gov ).

2 days ago . Aratana Therapeutics, a company developing medicines for companion animals,

12 hours ago . Aratana Therapeutics celebrates its first birthday this month, having taken steps.

Aratana Therapeutics. Main menu. HOME · ABOUT US · Aratana Team · Board of

Aratana Therapeutics, a newly-formed company focused on the development of

Nov 19, 2011 . Aratana Therapeutics, Inc. company research & investing information. Find

2 days ago . 7, 2011 /PRNewswire/ – Aratana Therapeutics, an animal health company

Aratana Therapeutics buys health product licenses from RaQualia Pharma. Aratana,

Aratana Therapeutics Company & Business Contact information- Jigsaw Business

Aratana Therapeutics, a company developing medicines for companion animals,

Aratana Therapeutics buys health product licenses from RaQualia Pharma. More

Incorporated: 10/2011; Air Transportation, Aircraft and parts, scheduled flights

2 days ago . Aratana Therapeutics, a Kansas City, KS-based animal health company

Company Profile. Aratana Therapeutics 1901 Olathe Blvd Kansas City Kansas 66103

2 days ago . MPM Capital, Avalon Ventures and Cultivian Ventures, all Series A investors,

1 day ago . Aratana Therapeutics, a company developing medicines for companion animals,

2 days ago . Aratana Therapeutics, a Kansas City, KS-based animal health company

Aratana Therapeutics, a Kansas City, Kansas-based newly-formed company

Dr. Linda Rhodes V.M.D., Ph.D. is Chief Executive Officer of Aratana

. to main content. Aratana Therapeutics . Opportunities for partnering with

Aratana Therapeutics has raised $15 million that will help the animal health

This was printed from Kansas City Business Journal Aratana Therapeutics has

Aratana Therapeutics is a privately-held, venture-backed pharmaceuticals company

2 days ago . Aratana Therapeutics, a company developing medicines for companion animals,

183 records . ARATANA THERAPEUTICS, INC. Form D Filed 2011-01-07.

2 days ago . Aratana Therapeutics Completes $15 Million Series B Financing.

Aratana Therapeutics leverages human pharmaceutical and biotechnology drug

2 days ago . KANSAS CITY, Kan., Dec. 7, 2011 /PRNewswire/ -- Aratana Therapeutics, an

Dr. Linda Rhodes is Chief Executive Officer of Aratana Therapeutics. Dr. Rhodes

2 days ago . Aratana Therapeutics has raised $15 million that will help the animal health

1 day ago . Kansas City, Missouri -- Animal health company Aratana Therapeutics has

1901 Olathe Blvd, Kansas City, KS, 66103-3326. Phone: . Category:

Aratana Therapeutics, Inc.: Series A $20M http://goo.gl/fb/h4Hi4.

Aratana Therapeutics is a company (BioTech) based out of KS. Avalon Ventures (

Aratana Therapeutics Inc. has bought the licenses for two Japanese products to

Aratana takes a unique approach to animal health by exploring novel

2 days ago . Aratana Therapeutics raises $15m in Series B financing | CenterWatch News

Find business contact information for David Rosen, President and Chief

2 days ago . Aratana Therapeutics, a company developing medicines for companion animals,

Aratana Therapeutics, a company developing medicines for companion animals,

News. Aratana Therapeutics announced today the closing of a $15 million Series

1 day ago . Aratana Therapeutics has closed a $15 million Series B financing, bringing the

Tracking and Analysis of 13f filings for institutional investment manager or

January 2011 – Present (11 months). Aratana Therapeutics is a venture capital-

Sitemap